Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (67)
- Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients 2026-11-10 · Expand citations
- High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis 2026-10-28 · Expand citations
- Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
- Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis 2026-10-08 · Expand citations
- Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders 2026-09-02 · Expand citations
- Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026) 2026-08-12 · Expand citations
- Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations
- Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex 2026-07-28 · Expand citations
- Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
- Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions 2026-07-03 · Expand citations
- Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study 2026-07-01 · Expand citations
- Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits 2026-07-01 · Expand citations
- Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults” 2026-06-30 · Expand citations
- Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments 2026-06-12 · Expand citations
- Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex 2026-06-01 · Expand citations
- Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
- Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial 2026-06-01 · Expand citations
- Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache 2026-05-29 · Expand citations
- Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder 2026-05-26 · Expand citations
- Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression 2026-05-15 · Expand citations
- Psilocybin in the Treatment of Cocaine Use Disorder 2026-05-07 · Expand citations
- Human brain changes after first psilocybin use 2026-05-05 · Expand citations
- Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression 2026-05-01 · Expand citations
- Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms 2026-05-01 · Expand citations
- Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics 2026-04-30 · Expand citations
- Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey 2026-04-15 · Expand citations
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
- Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons 2026-03-27 · Expand citations
- Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD) 2026-03-26 · Expand citations
- Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
- Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution 2026-03-19 · Expand citations
- Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs 2026-03-18 · Expand citations
- Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations
- Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention 2026-03-01 · Expand citations
- A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations 2026-02-28 · Expand citations
- THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026-01-22 · Expand citations
- Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy" 2026-01-01 · Expand citations
- Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study 2025-12-19 · Expand citations
- The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice 2025-12-10 · Expand citations
- Psychedelics for the Treatment of Substance Use Disorders 2025-12-01 · Expand citations
- Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics 2025-12-01 · Expand citations
- Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience 2025-11-20 · Expand citations
- Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report 2025-09-01 · Expand citations
- Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics 2025-06-29 · Expand citations
- Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review 2025-05-02 · Expand citations
- Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study 2025-04-30 · Expand citations
- University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis 2025-04-26 · Expand citations
- Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis 2025-04-24 · Expand citations
- Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee 2025-03-06 · Expand citations
- Psilocybin: revealing the enigmas of a revolutionary fungi 2025-01-01 · Expand citations
- An Early Exploration into Individuals in Treatment Who Co-Use Alcohol and Hallucinogens 2024-10-15 · Expand citations
- The Psychedelic Renaissance: A Catholic Perspective 2024-09-14 · Expand citations
- An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States 2024-09-13 · Expand citations
- Insights into the efficacy of psilocybin in treating depression and other disorders 2024-08-01 · Expand citations
- From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions 2024-07-28 · Expand citations
- Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30) 2024-07-12 · Expand citations
- Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
- Therapeutic Implications of Psilocybin in the Wake of Decriminalization 2024-06-01 · Expand citations
- Managing expectations with psychedelic microdosing 2023-11-08 · Expand citations
- Pharmacists’ perspectives on psilocybin in Canada 2023-11-08 · Expand citations
- Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
- Can a single dose of psilocybin improve cognitive control in functional dissociative seizures? 2023-09-09 · Expand citations
- use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations
- A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history 2023-04-26 · Expand citations
- The therapeutic potential of psychedelics: the European regulatory perspective 2023-02-10 · Expand citations
- Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum 2022-12-07 · Expand citations
- Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects 2022-12-01 · Expand citations